Drugs / 6-DIG
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02102737 | May 2014 → Mar 2018 | diabetes mellitus | French National Institute of Health and Medical Research | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 6-DIG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02102737 ↗ |
| Modality | Diagnostic / imaging agent | “a new nuclear probe using an iodinated tracer of glucose transport for clinical application” NCT02102737 ↗ |